OFI Invest Asset Management Has $39.72 Million Position in Colgate-Palmolive Company $CL

OFI Invest Asset Management raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 35,047.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 502,615 shares of the company’s stock after purchasing an additional 501,185 shares during the quarter. OFI Invest Asset Management owned 0.06% of Colgate-Palmolive worth $39,717,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. ProShare Advisors LLC grew its holdings in shares of Colgate-Palmolive by 11.0% during the 3rd quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock valued at $163,681,000 after acquiring an additional 202,379 shares in the last quarter. Providence Capital Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $5,373,000. Asset Management One Co. Ltd. grew its holdings in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after acquiring an additional 16,017 shares in the last quarter. Citigroup Inc. grew its holdings in shares of Colgate-Palmolive by 43.7% during the 3rd quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock valued at $107,646,000 after acquiring an additional 409,710 shares in the last quarter. Finally, TD Waterhouse Canada Inc. grew its holdings in shares of Colgate-Palmolive by 248.5% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock valued at $6,909,000 after acquiring an additional 62,327 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 2.9%

Shares of NYSE:CL opened at $85.54 on Thursday. The stock has a market capitalization of $68.63 billion, a PE ratio of 32.65, a P/E/G ratio of 3.91 and a beta of 0.34. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The firm has a fifty day moving average price of $91.04 and a 200 day moving average price of $83.52. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be issued a $0.53 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the sale, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This trade represents a 59.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 184,683 shares of company stock valued at $17,486,693. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: UBS trimmed its price target to $98 (from $100) but kept a Buy rating, signaling continued conviction in Colgate’s fundamentals and supporting demand among buy‑side investors. UBS lowers price target to $98 but keeps Buy
• Positive Sentiment: Colgate‑Palmolive was included on a list of best low‑volatility blue‑chip stocks, reinforcing its defensive/steady‑growth narrative (appealing to income and risk‑averse investors given CL’s low beta). InsiderMonkey low‑volatility list
• Positive Sentiment: Analysts’ consensus remains above neutral (reported as a “Moderate Buy”), which helps sustain investor confidence despite some target cuts. Consensus Moderate Buy report
• Neutral Sentiment: Piper Sandler lowered its target from $96 to $92 but maintained an Overweight rating — a mixed signal that trims upside expectations while still backing the stock. Piper Sandler cuts target to $92, keeps Overweight Benzinga
• Negative Sentiment: Wells Fargo cut its price target to $92 and moved to an Equal Weight rating — a clearer downside pressure on near‑term sentiment because it reduces the analyst‑driven upside case. Wells Fargo cuts target to $92, downgrades to EW

Analyst Upgrades and Downgrades

CL has been the topic of several research analyst reports. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Barclays boosted their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. TD Cowen restated a “hold” rating and set a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Finally, Bank of America boosted their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $95.13.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.